Ground News

News from Finnoexpert

Stay current with all the latest and breaking news from Finnoexpert. Compare headlines and media bias behind news outlets on stories breaking today.

Ground News has come across 825 headlines reported on by Finnoexpert during the past 3 months.

Ground News rates Finnoexpert’s media bias as unknown. . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

If you want to know if Finnoexpert is credible or reliable, look no further. We rank Finnoexpert as Unknown factuality. Find out more about our methodology here.

Information about Finnoexpert

Where is Finnoexpert located?Finnoexpert's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Finnoexpert News

Joe Biden · United States

Biden Aides Floated Wheelchair Use in Second Term, Book by Tapper and Thompson Says

45% Right coverage: 85 sources

Former President Joe Biden’s physical deterioration was severe enough in the second half of his presidency that his aides privately discussed putting him in a wheelchair for his second term, according to a new book from CNN’s Jake Tapper and Axios’ Alex Thompson.See the Story

Tariffs · United States

Trump's 'Doll Analogy' Fuels Debate Over Tariffs and Consumer Culture

50% Left coverage: 70 sources

See the Story

Shanghai, China · Shanghai

Abbisko Therapeutics to Present Updated Results from the Phase 2 Study of Irpagratinib in Combination with Atezolizumab for the Treatment of Advanced Hepatocellular Carcinoma at the 2025 ESMO GI Congress

86% Center coverage: 22 sources

SHANGHAI, May 12, 2025 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. (02256.HK) today announced that updated results from the phase 2 study of irpagratinib (ABSK011) in combination with atezolizumab for the treatment of advanced hepatocellular carcinoma (HCC) will be presented at…See the Story

Blindspots

Justice Department plans to investigate prosecutor’s office in Minnesota’s most populous county

6 of 61 Sources Lean Left

Low coverage from Left Sources

8d ago

Justice Department plans to investigate prosecutor’s office in Minnesota’s most populous county

UnitedHealth sued by shareholders over its reaction to backlash from executive's killing

1 of 23 Sources Lean Right

Low coverage from Right Sources

4d ago

News from Finnoexpert